{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:14:06Z","timestamp":1787606046511,"version":"build-2736575974"},"reference-count":45,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T00:00:00Z","timestamp":1274486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:italic>Aliment Pharmacol Ther<\/jats:italic> 2010; <jats:bold>32:<\/jats:bold> 401\u2013413<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Gastroprotective co\u2010therapy may reduce the risk of nonsteroidal anti\u2010inflammatory drug (NSAID)\u2010associated gastric ulcers, but adherence is suboptimal.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To compare the incidence of gastric ulcers with PN 400 [enteric\u2010coated (EC) naproxen 500\u2003mg and immediate\u2010release esomeprazole 20\u2003mg], or EC naproxen.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Two randomized, double\u2010blind, multicentre studies (PN400\u2010301, PN400\u2010302). Patients [stratified by low\u2010dose aspirin (\u2264325\u2003mg) use] aged \u226550\u2003years or 18\u201349\u2003years with a history of ulcer, received PN 400 BID (301, <jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>218; 302, <jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>210) or EC naproxen 500\u2003mg BID (301, <jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>216; 302, <jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>210) for 6\u2003months. The primary endpoint was the cumulative incidence of endoscopic gastric ulcers.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The cumulative incidence of gastric ulcers was significantly lower with PN 400 vs. EC naproxen (301: 4.1% vs. 23.1%, <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.001; 302: 7.1% vs. 24.3%, <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.001). PN 400 was associated with a lower combined incidence of gastric ulcers vs. EC naproxen in low\u2010dose aspirin users (<jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>201) (3.0% vs. 28.4%, <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.001) and non\u2010users (<jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>653) (6.4% vs. 22.2%, <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.001). The incidence of, and discontinuations due to, upper gastrointestinal (UGI) AEs was significantly lower with PN 400 relative to EC naproxen (<jats:italic>P\u2003&lt;\u2003<\/jats:italic>0.01, both studies).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> PN 400 significantly reduces the incidence of gastric ulcers, regardless of low\u2010dose aspirin use, in at\u2010risk patients, and is associated with improved UGI tolerability relative to EC naproxen (ClinicalTrials.gov, NCT00527782).<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04378.x","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T13:57:52Z","timestamp":1274882272000},"page":"401-413","source":"Crossref","is-referenced-by-count":61,"title":["Clinical trial: the incidence of NSAID\u2010associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric\u2010coated naproxen alone"],"prefix":"10.1111","volume":"32","author":[{"given":"J. L.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"Fort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sostek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21562"},{"key":"e_1_2_7_3_2","first-page":"646","article-title":"Burden of major musculoskeletal conditions","volume":"81","author":"Woolf AD","year":"2003","journal-title":"Bull World Health Organ"},{"key":"e_1_2_7_4_2","unstructured":"World Health Organization.The Global Burden of Disease: 2004 Update 2008. Available at:http:\/\/www.who.int\/healthinfo\/global_burden_disease\/2004_report_update\/en\/index.html. Accessed November 3 2008."},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23929"},{"key":"e_1_2_7_6_2","unstructured":"National Institute for Health and Clinical Excellence.The Care and Management of Osteoarthritis in Adults. NICE Clinical Guideline 59 2008. Available at:http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG59NICEguideline.pdf. Accessed September 12 2008."},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.028886"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2007.12.013"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02200.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.115"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.21907"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-4-199508150-00001"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36013"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03523.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00499.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.2.169"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803123381105"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60722-3"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.08.003"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04085.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04090.x"},{"issue":"1","key":"e_1_2_7_22_2","first-page":"S108","article-title":"Types of prescription and levels of adherence to NSAIDs and gastroprotectors in at\u2010risk GI patients","volume":"138","author":"Lanas A","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"e_1_2_7_23_2","first-page":"iii23","article-title":"Underutilization of preventive strategies in patients receiving NSAIDs","volume":"42","author":"Sturkenboom MCJM","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03713.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.08.016"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01795.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(09)62816-X"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(09)62816-X"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(00)00365-6"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05419.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(89)90005-6"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.06.006"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.03.032"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03210.x"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.04.031"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021907"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.07.010"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60749-1"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03780.x"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.058"},{"key":"e_1_2_7_41_2","first-page":"1602","article-title":"Diclofenac\/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group","volume":"25","author":"Bocanegra TS","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_7_42_2","doi-asserted-by":"crossref","unstructured":"LaineLA SchiffM GenoveseM et\u00a0al.Does High\u2010Dose Famotidine Reduce Gastric and Duodenal Ulcers in NSAID Users? Two Double\u2010Blind six\u2010Month Trials of Single\u2010Tablet Combination Ibuprofen\u2010Famotidine vs Ibuprofen Alone (Reduce\u20101 and 2). Abstract presented at theDigestive Disease Week Chicago IL USA2009 (abs 407).","DOI":"10.1016\/S0016-5085(09)60310-3"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.10.002"},{"key":"e_1_2_7_44_2","first-page":"S10","article-title":"The impact of nonsteroidal anti\u2010inflammatory drug\u2010induced gastropathy","volume":"7","author":"Scheiman JM","year":"2001","journal-title":"Am J Manag Care"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.11.020"},{"key":"e_1_2_7_46_2","first-page":"1373","article-title":"Gastrointestinal symptoms and health related quality of life in patients with arthritis","volume":"27","author":"Wolfe F","year":"2000","journal-title":"J Rheumatol"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04378.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04378.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:29:05Z","timestamp":1698737345000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04378.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04378.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04378.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,6]]}}}